Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
45.43
+2.93 (6.89%)
Jul 3, 2025, 1:00 PM - Market closed
Claritev Market Cap
Claritev has a market cap or net worth of $746.70 million as of July 3, 2025. Its market cap has increased by 166.13% in one year.
Market Cap
746.70M
Enterprise Value
5.36B
1-Year Change
166.13%
Ranking
Category
Stock Price
$45.43
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $746.70M, an increase of 207.29%. That is a compound annual growth rate of 23.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 698.55M | 192.27% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.55B |
| Johnson & Johnson | 375.15B |
| AbbVie | 335.60B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 295.85B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 237.07B |
| AstraZeneca | 221.11B |